These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16735966)
1. Lymphocyte ecto-5'-nucleotidase in obese type 2 diabetic patients treated with gliclazide. Stefanovic V; Antic S; Milojkovic M; Lazarević G; Vlahovic P Diabetes Metab; 2006 Apr; 32(2):166-70. PubMed ID: 16735966 [TBL] [Abstract][Full Text] [Related]
2. The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5'-nucleotidase in rat hearts. Sato T; Obata T; Yamanaka Y; Arita M Br J Pharmacol; 1997 Oct; 122(4):611-8. PubMed ID: 9375955 [TBL] [Abstract][Full Text] [Related]
3. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3. Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide. van der Wal PS; Heine RJ Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964 [TBL] [Abstract][Full Text] [Related]
5. Activation of ecto-5'-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. Kitakaze M; Minamino T; Node K; Komamura K; Inoue M; Hori M; Kamada T J Mol Cell Cardiol; 1996 Sep; 28(9):1945-55. PubMed ID: 8899553 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes. Betteridge DJ; Vergès B Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239 [TBL] [Abstract][Full Text] [Related]
7. Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Okazaki Y; Node K; Komamura K; Iwakura K; Itoh T Circulation; 1995 Apr; 91(8):2226-34. PubMed ID: 7697853 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of ecto-5'-nucleotidase activity and adenosine release in activated human polymorphonuclear leukocytes. Kitakaze M; Hori M; Morioka T; Takashima S; Minamino T; Sato H; Inoue M; Kamada T Circ Res; 1993 Sep; 73(3):524-33. PubMed ID: 8348695 [TBL] [Abstract][Full Text] [Related]
9. Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. Wolffenbuttel BH; Gomis R; Squatrito S; Jones NP; Patwardhan RN Diabet Med; 2000 Jan; 17(1):40-7. PubMed ID: 10691158 [TBL] [Abstract][Full Text] [Related]
10. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study. Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468 [TBL] [Abstract][Full Text] [Related]
11. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide. Jennings PE; Belch JJ Metabolism; 2000 Feb; 49(2 Suppl 1):23-6. PubMed ID: 10693916 [TBL] [Abstract][Full Text] [Related]
12. Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients. De Mattia G; Laurenti O; Fava D J Diabetes Complications; 2003; 17(2 Suppl):30-5. PubMed ID: 12623166 [TBL] [Abstract][Full Text] [Related]
13. The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy. Saberi M; Ramazani Z; Rashidi H; Saberi A Vasc Health Risk Manag; 2020; 16():241-248. PubMed ID: 32606720 [TBL] [Abstract][Full Text] [Related]
14. Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure. Fujita M; Asakura M; Sanada S; Funaya H; Tsukamoto O; Komamura K; Asanuma H; Taketani S; Isomura T; Nakamaru K; Furukawa H; Sawa Y; Hori M; Kitakaze M J Card Fail; 2008 Jun; 14(5):426-30. PubMed ID: 18514936 [TBL] [Abstract][Full Text] [Related]
15. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide]. Jennings PE; Belch JJ Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442 [TBL] [Abstract][Full Text] [Related]
16. Reserpine attenuates interstitial adenosine-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo. Obata T; Yamanaka Y Arch Biochem Biophys; 2000 Mar; 375(2):333-9. PubMed ID: 10700389 [TBL] [Abstract][Full Text] [Related]
18. Association of gliclazide and left ventricular mass in type 2 diabetic patients. Pan NH; Lee TM; Lin MS; Huang CL; Chang NC Diabetes Res Clin Pract; 2006 Nov; 74(2):121-8. PubMed ID: 16631274 [TBL] [Abstract][Full Text] [Related]
19. Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study. Khalangot M; Tronko M; Kravchenko V; Kovtun V Diabetes Res Clin Pract; 2009 Dec; 86(3):247-53. PubMed ID: 19796836 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin, an HMG-CoA reductase inhibitor, facilitate adenosine production in the rat hearts via activation of ecto-5'-nucleotidase. Obata T; Nakashima M Microvasc Res; 2016 Sep; 107():1-5. PubMed ID: 27102210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]